Semaglutide

This medication, similar to the hormone glucagon-like peptide-1, is primarily used for managing type 2 diabetes and long-term weight. It can be administered orally or through subcutaneous injection. With a bioavailability of 89% and a duration of action of 63.6 hours, it is metabolized through proteolysis and has an elimination half-life of 7 days.